Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:07 AM
Ignite Modification Date:
2025-12-25 @ 4:07 AM
NCT ID:
NCT02272920
Eligibility Criteria:
Inclusion Criteria:
1. Provision of informed consent prior to any study specific procedures
2. Female and/or male aged 18-80 years
3. Patients with ACS, i.e. STEMI, non-STEMI, treated with PCI
4. Medical history of treated (ongoing) hypertension, or hypertension discovered at the time of ACS, and office SBP \>140 despite treatment with three antihypertensive drugs.
5. Ejection fraction \>40%.
Exclusion Criteria:
1. Increased risk of pathological bleedings
2. Office systolic blood pressure \<120
3. Renal artery abnormalities.
4. eGFR \<30 mL/min
5. ICD or pacemaker, or any other metallic implant not compatible with MRI
6. Estimated survival time \<1 year
7. Not oriented to person, place and time
8. Inability to understand given information about the study
9. Fertile female
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT02272920
Study Brief:
Protocol Section:
NCT02272920